Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: CureVac’s IPO Is Ready For Launch

Aug 11 2020

• By Mandy Jackson

Finance Watch

Related Content

Corbus Takes On New Cystic Fibrosis Endpoint With Lenabasum

Jan 31 2018

Keeping Track: Tecentriq, Cyramza Celebrate ASCO With New Indications; Brilinta Moves Earlier In Coronary Artery Disease

Jun 08 2020

Finance Watch: BioGeneration Ventures, Autobahn Labs Offer New Start-Up Resources

Jul 02 2020

BioXcel Turns To Commercialization With Positive Phase III Data In Agitation

Jul 20 2020

Can An Antibody Cocktail Block COVID-19 Infection? Regeneron’s Warp Speed Research Aims To Find Out Soon

Jul 27 2020

$3bn Roivant Deal To Fill Holes At Dainippon

Sep 06 2019

Finance Watch: Anchiano, TCR2, Hoth And Stealth Make Seven US Biopharma IPOs For 2019

Feb 25 2019

Finance Watch: Four Offerings In One Week As Biopharma Keeps Its IPO Market Lead

Jun 15 2020

‘Friendly Breakup’: Sanofi And Regeneron Agree Equity Revamp

May 26 2020

ElevateBio Announces AlloVir As First Spoke In Its Cell And Gene Therapy Hub

May 23 2019

Immatics To Go Public Through Merger With ‘Blank Check’ Company Arya

Mar 18 2020

IPO Update: High-Flying Biopharma IPOs Average 77.1% Return Through Q2

Jun 30 2020

Next Generation SERDs Progress In Breast Cancer; Standing Out In The Crowd Won't Be Easy

Jun 04 2020

Market Snapshot: Three Acute Migraine Launches Are First In Over 20 Years

Jan 27 2020

Finance Watch: Intrexon Reorganizes, Raises Cash And Becomes Precigen

Jan 03 2020

Myovant's Relugolix Shows Promising Profile For Endometriosis Pain

Apr 22 2020

Finance Watch: Biopharma Fundraising Impact Expected, But Not Apparent Yet

Apr 17 2020

Finance Watch: ORIC Raises $120m In Another Pandemic Era Biopharma IPO

Apr 25 2020

Horizon Heralds Stellar Launch Of TED Drug Tepezza

Aug 06 2020

Related Companies

CureVac NV

AlloVir, Inc.

Checkmate Pharmaceuticals, Inc.

Spur Therapeutics Limited

Pfizer Inc.

BioNTech SE

Moderna, Inc.

Cerevel Therapeutics Holdings, Inc.

Regeneron Pharmaceuticals, Inc.

Biohaven Pharmaceutical Holding Company Ltd.

Royalty Pharma plc

Horizon Therapeutics plc

Myovant Sciences Ltd.

Sumitomo Pharma Co., Ltd.

Sumitovant Biopharma Ltd.

BioXcel Therapeutics, Inc.

Zentalis Pharmaceuticals

Eli Lilly and Company

Corbus Pharmaceuticals Holdings, Inc.

Immunic Inc.

Additional Topics

Financing Business Strategies Innovation Coronavirus COVID-19 Growth Commercial BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.